Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients

Blood Pressure

Volumn 20, Issue 3, 2011, Pages 182-187

  Dogan, Ali ^a   Yarlioglues, Mikail ^a   Kaya, Mehmet Gungor ^a   Karadag, Zakir ^b   Dogan, Serap ^a   Ardic, Idris ^a   Dogdu, Orhan ^a   Kilinc, Yusuf ^a   Zencir, Cemil ^a   Akpek, Mahmut ^a   Ozdogru, Ibrahim ^a   Oguzhan, Abdurrahman ^a   Kalay, Nihat ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Rize Training and Research Hospital ^*  (Turkey)

Author keywords

Allopurinol; diabetes mellitus; flow mediated dilatation

Indexed keywords

ALLOPURINOL; HEMOGLOBIN A1C; NITRATE; UNCLASSIFIED DRUG; URIC ACID; URIKOLIZ;

ADULT; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FLOW MEDIATED DILATATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NITRATE INDUCED DILATATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; URIC ACID BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ALLOPURINOL; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NITRATES; OXIDATIVE STRESS; TURKEY; URIC ACID; VASODILATION; XANTHINE OXIDASE;

EID: 79957524603     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.538977     Document Type: Article

References (26)

1. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992 National Health and Nutrition Examination Survey. JAMA. 2000;283: 2404-2410 (Pubitemid 30257539)
2. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract. 2005;59: 1276-1282 (Pubitemid 43904496)
3. Wolff SP. Diabetes mellitus and free radicals: Free radicals, transition metals and oxidative stress in the etiology of diabetes mellitus and complications. Br Med Bull. 1993;49: 642-652 (Pubitemid 23243836)
4. Schroeder S, Enderle MD, Ossen R, Meisner C, Baumbach A, Pfohl M, et al. Noninvasive determination of endotheliummediated vasodilation as a screening test for coronary artery disease: Pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J. 1999;138 (4 Pt 1): 731-739 (Pubitemid 29471049)
5. Freidl HP, Smith DJ, Till GO. Ischaemia-reperfusion in humans: Appearance of xanthine oxidase activity. Am J Pathol. 1990;136: 491
6. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35: 746-751 (Pubitemid 30165320)
7. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Reactivity Task Force vasodilation of the brachial artery: A report of the International Brachial Artery Guidelines for the ultrasound assessment of endothelial-dependent fl ow-mediated. J. Am. Coll. Cardiol. 2002;39: 257-265 (Pubitemid 34084631)
8. Celermajer DS. Endothelial dysfunction: Does it matter? Is it reversible? J Am Coll Cardiol. 1997;30: 325-333 (Pubitemid 27339309)
9. Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation. 2004; 109: 27-33
10. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997;129: 111-118 (Pubitemid 27104258)
11. Chan SY, Mancini GBJ, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol. 2003;42: 1037-1043 (Pubitemid 37108590)
12. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40: 505-510 (Pubitemid 34833167)
13. Nair BM, Viswanathan V, Snehalatha C, Mohan RS, Ramachandran A. Flow mediated dilatation and carotid intimal media thickness in South Indian type 2 diabetic subjects. Diabetes Res Clin Pract. 2004;65: 13-19 (Pubitemid 38649044)
14. Sibal L, Agarwal SC, Schwedhelm E, Lü neburg N, Bö g er RH, Home PD. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. Cardiovasc Diabetol. 2009;8: 27
15. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, et al. Type 2 diabetes is associated with impaired endothelium-dependent, fl ow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis. 2004;174: 49-56 (Pubitemid 38595439)
16. D oehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood fl ow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies. Circulation. 2002;105: 2619-2623
17. Guthikonda S, Sinkey C, Barenz T, Haynes WG. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation. 2003;107: 416-421 (Pubitemid 36158043)
18. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114: 2508-2516 (Pubitemid 44901524)
19. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004;94: 932-935 (Pubitemid 39349561)
20. Cuspidi C, Valerio C, Sala C, Meani S, Esposito A, Zanchetti A, et al. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens. 2007;20: 678-685 (Pubitemid 46777264)
21. Desco MC, Asensi M, Ma´ r quez R, Martí nez-Valls J, Vento M, Pallard o´ FV, et al. Xanthine oxidase is involved in free radicalproduction in type 1 diabetes: Protection by allopurinol. Diabetes. 2002;51: 1118-1124 (Pubitemid 34438358)
22. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for fl ow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91: 1314-1319
23. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular disease. Circ Res. 1997;100: 2153-2157
24. Borges RL, Ribeiro AB, Zanella MT, Batista MC. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep. 2010;12: 113-119
25. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266: 3008-3011
26. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003;88: 4673-4676 (Pubitemid 37357510)